|
关键字
|
AH10141,AMM00096G, Carcinoembryonic Antigen (CEA) / CD66 Antibody - With BSA and Azide,Leading biology,abgent
|
|
产品描述
|
Certainly! Below is an improved product information outline for the Carcinoembryonic Antigen (CEA) / CD66 Antibody with BSA and Azide, covering storage, product description, key features, what's included, and applications.
---
Carcinoembryonic Antigen (CEA) / CD66 Antibody with BSA and Azide
Storage
- Temperature: Store at 2-8°C for short-term use. For long-term storage, keep at -20°C.
- Stability: Avoid repeated freeze-thaw cycles to maintain antibody integrity.
- Buffer: Supplied in a buffer containing BSA and sodium azide to enhance stability and prevent microbial growth.
Product Description
- Type: Monoclonal antibody specific to Carcinoembryonic Antigen (CEA) / CD66.
- Host Species: Typically produced in mouse or rabbit.
- Formulation: Provided in a buffer solution with Bovine Serum Albumin (BSA) as a stabilizer and sodium azide as a preservative.
- Concentration: Variable, typically ranging from 0.1 mg/mL to 1 mg/mL.
Key Features
- High Specificity: Recognizes CEA/CD66 with minimal cross-reactivity to other proteins.
- Enhanced Stability: Formulated with BSA and azide to maintain activity over time.
- Versatile Use: Suitable for a range of applications including ELISA, Western blotting, immunohistochemistry, and flow cytometry.
- Quality Control: Each batch undergoes rigorous testing to ensure consistent performance.
What's Included
- Antibody Solution: A specified volume of CEA/CD66 antibody in stabilized buffer.
- Data Sheet: Detailed information on the antibody's characteristics and recommended protocols.
- Certificate of Analysis: Document confirming the product's specifications and performance criteria.
Applications
- Research: Used in cancer research to detect and quantify CEA in various sample types, aiding in the study of tumor markers and cancer progression.
- Clinical Diagnostics: Potential use in diagnostic assays for monitoring CEA levels in cancer patients.
- Biomarker Studies: Facilitates the investigation of CEA as a biomarker in oncology and other related fields.
- Therapeutic Development: Assists in the development of CEA-targeted therapies.
---
This information serves as a comprehensive guide for users, ensuring proper usage and storage of the CEA/CD66 antibody to achieve optimal results in various applications.
|